Abstract
Liver failure is associated to high mortality due to the accumulation of protein-bound metabolites, such as bilirubin, not removed by conventional hemodialysis. Different methods can efficiently remove them, such as the molecular adsorbent recirculating system (MARS), plasma exchange (PEX), and bilirubin or plasma adsorption perfusion (PAP). No direct comparison exists between MARS, PEX and PAP, and current guidelines do not specify which method (and when) to use. We have retrospectively evaluated MARS, PEX and PAP in their effectiveness in lowering plasma bilirubin concentration, and their effects on liver and kidney function. A total of 98 patients have been recruited, which comprised 68 patients treated with PAP (177 sessions), 16 patients with PEX (41 sessions) and 11 patients with MARS (21 sessions). Bilirubin, creatinine, liver enzymes were analyzed before and after the first treatment with each technique. The three methods did not differ for bilirubin lowering efficiency, with MARS showing only slightly less effective reductions. Finally, the three techniques did not differ in the amount of change of cholinesterase, but a lower reduction in AST was found using PAP. Our retrospective observation is one of the largest case series of hepatic failure treated with bilirubin absorption. The choice of the technique cannot be based on the desired reduction in bilirubin concentration. Based on costs and duration of treatment, we suggest that PAP could be considered as a first-line approach. In case of kidney involvement, MARS remains a valuable option.
Similar content being viewed by others
References
Hansen TW. Bilirubin brain toxicity. J Perinatol. 2001;21:S48–51.
Bach DR, Kindler J, Strik WK. Elevated bilirubin in acute and transient psychotic disorder. Pharmacopsychiatry. 2010;43:12–6. doi:10.1055/s-0029-1237376 (Epub 2009 Dec 10).
Rafat C, Burbach M, Brochériou I, Zafrani L, Callard P, Rondeau E, Hertig A. Bilirubin-associated acute tubular necrosis in a kidney transplant recipient. Am J Kidney Dis. 2013;61:782–5.
Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med. 2010;10:22. doi:10.1186/1471-2466-10-22.
Uslu A, Cayci M, Nart A, Karaca C, Zalluhoglu N, Gürkan A, Varilsuha C, Adagülü H. Renal failure in obstructive jaundice. Hepatogastroenterology. 2005;52:52–4.
Patzer J. Principles of bound solute dialysis. Ther Apher Dial. 2006;10:118–24.
Mandal AK, King KE, Humphreys SL, Maley WR, Burdick JF, Klein AS. Plasmapheresis: an effective therapy for primary allograft nonfunction after liver transplantation. Transplantation 2000;70:216–20.
Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993;17:809–13.
Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. Prometheus—a new extracorporeal system for the treatment of liver failure. J Hepatol. 2003;39:984–90.
Ott R, Rupprecht H, Born G, Müller V, Reck T, Hohenberger W, Köckerling F. Plasma separation and bilirubin adsorption after complicated liver transplantation: a therapeutic approach to excessive hyperbilirubinemia. Transplantation 1998;65:434–7
Adani GL, Lorenzin D, Currò G, Sainz-Barriga M, Comuzzi C, Bresadola V, Avellini C, Baccarani U. Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction. Transplant Proc. 2007;39:1904–6.
Senf R, Klingel R, Kurz S, Tullius S, Sauer I, Frei U, Schindler R. Bilirubin-adsorption in 23 critically ill patients with liver failure. Int J Artif Organs. 2004;27:717–22.
Mitzner SR, Jan Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G. Extra-corporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol. 2001;12:S75–82.
Davenport A. Extracorporeal support for patients with hepatic failure. Hemodial Int. 2003;7:256–63.
Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transplant. 2004;10:1099–106.
Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, Novelli S, Piemonte V, Turchetti L, Morabito V, Annesini MC, Berloco PB. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. Ther Apher Dial. 2009;13:404–12.
Coşkun R, Uslup S, Gündoğan K, Pala C, Akbudak IH, Sungur M, Güven M. The Effectiveness of bilirubin column on severe hyperbilirubinemia in a patient with cardiac cirrhosis. Erciyes Med J. 2014;36:82–4.
Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V, RELIEF study group. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153–62.
Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL. The new approach to assignment of ASFA categories introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher. 2007;22:96–105.
LópezVelázquez JA, Chávez-Tapia NC, Ponciano-Rodríguez G, Sánchez-Valle V, Caldwell SH, Uribe M, Méndez-Sánchez N. Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator. Ann Hepatol. 2014;13:98–104.
Chamuleau RA, Aronson DC, Frederiks WM, Bosman DK, Smit JJ, Maas MA, Jansen PL. Liver regeneration after partial hepatectomy in rats with defective bilirubin conjugation or biliary excretion. Dig Dis Sci. 1991;36:510–2.
Hassanein TI, Schade RR, Hepburn IS. Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care. 2011;17:195–203.
Lee JY, Kim SB, Chang JW, Park SK, Kwon SW, Song KW, Hwang S, Lee SG. Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation. Transplant Proc. 2010;42:2625–30.
Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP. Comparison of molecular adsorbents recirculating system (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant. 2011;26:3633–9.
Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Effect of the molecular adsorbent recirculating system and prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108.
Dethloff T, Tofteng F, Frederiksen HJ, Hojskov M, Hansen BA, Larsen FS. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol. 2008;14:2065–71.
Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43:451–7.
Gong D, Cruz D, Ronco C. Depurative capacity of molecular adsorbent recycling system (MARS): a focus on bilirubin removal. Int J Artif Organs. 2008;31:875–81.
Gong D, Ji D, Ren B, Tao J, Xu B, Ronco C, Li L. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Int J Artif Organs. 2008;31:333–9.
Steiner C, Sen S, Stange J, Williams R, Jalan R. Binding of bilirubin and bromo-sulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management. Liver Transpl. 2004;10:1531–8.
Rozga J, Malkowski P. Artificial liver support: quo vadis? Ann Transplant. 2010;15:92–101.
Nakae H, Eguchi Y, Saotome T, Yoshioka T, Yoshimura N, Kishi Y, Naka T, Furuya T. Multicenter study of plasma diafiltration in patients with acute liver failure. Ther Apher Dial 2010;14:444–50.
Santoro A, Mancini E, Ferramosca E, Faenza S. Liver support systems. In: Ronco C, Bellomo R, Kellum JA, editors. Acute kidney injury. Contrib Nephrol. Basel, Karger, 2007. Vol. 156, p. 396–404.
Rademacher S, Oppert M, Jörres A. Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol. 2011;5:591–9.
Acknowledgements
We are grateful to Dr. Alfonso Ramunni for critical reading and suggestions.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Davide Viggiano, Emanuela de Pascale and Gaia Marinelli should be considered as equal contributors.
Rights and permissions
About this article
Cite this article
Viggiano, D., de Pascale, E., Marinelli, G. et al. A comparison among three different apheretic techniques for treatment of hyperbilirubinemia. J Artif Organs 21, 110–116 (2018). https://doi.org/10.1007/s10047-017-0986-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-017-0986-1